Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Conmed Corp shares valued at $10,591 were sold by Glaze Richard on Nov 21 ’25. At $41.21 per share, Glaze Richard sold 257 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Glaze Richard purchased 257 shares, netting a total of over 10,591 in proceeds.
Before that, Garner Todd W had sold 3,500 shares from its account. In a trade valued at $150,500, the Executive Vice President & CFO traded Conmed Corp shares for $43.00 each. Upon closing the transaction, the insider’s holdings decreased to 3,500 shares, worth approximately $73164.6.
As published in a research note from Needham on June 12, 2025, Conmed Corp [CNMD] has been rated down from a Buy to a Hold. Analysts at Stifel downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late April. As of February 06, 2025, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for CNMD. Earlier on February 01, 2024, Needham resumed its rating. Their recommendation was “a Buy” for CNMD stock.
Analyzing CNMD Stock Performance
On last trading session, Conmed Corp [NYSE: CNMD] rose 2.07% to $39.85. The stock’s lowest price that day was $38.79, but it reached a high of $40.4 in the same session. During the last five days, there has been a drop of approximately -9.92%. Over the course of the year, Conmed Corp shares have dropped approximately -46.65%. Shares of the company reached a 52-week high of $74.70 on 02/05/25 and a 52-week low of $38.32 on 12/10/25.
Support And Resistance Levels for Conmed Corp (CNMD)
According to the 24-hour chart, there is a support level at 38.96, which, if violated, would cause prices to drop to 38.07. In the upper region, resistance lies at 40.57. The next price resistance is at 41.29. RSI (Relative Strength Index) is 37.02 on the 14-day chart, showing neutral technical sentiment.
Is Conmed Corp subject to short interest?
Stocks of Conmed Corp saw a sharp rise in short interest on 2025-11-28 jumping by 26546.0 shares to 2.32 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 2.3 million shares. A jump of 1.14% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.31 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.31.
Which companies own the most shares of Conmed Corp (CNMD)?
In terms of Conmed Corp share price expectations, FactSet research, analysts set an average price target of 78 in the next 12 months, up nearly 99.8% from the previous closing price of $39.04. Analysts anticipate Conmed Corp stock to reach 95 by 2025, with the lowest price target being 61. In spite of this, 4 analysts ranked Conmed Corp stock as Buy at the end of 2025. On May 22, 2023, CL King assigned a price target of “a Buy” to the stock and initiated coverage with a $140.
